The IS MPT system mandates sophisticated product serialization through DataMatrix codes containing multiple data elements - a 14-digit Global Trade Item Number (GTIN), a 13-character randomized serial number, a 4-character verification key, and a 44-character verification code. This multi-layered approach provides robust cryptographic protection and enables precise tracking throughout the pharmaceutical supply chain.

Kazakhstan's traceability framework leverages a centralized digital ecosystem that connects manufacturers, distributors, retailers, and consumers. The system's digital architecture facilitates real-time data exchange, creates digital product passports, and enables seamless integration with the broader Eurasian Economic Union (EAEU) traceability networks, fostering regional harmonization of pharmaceutical regulations.

The IS MPT system places verification capabilities directly in consumers' hands through the NAQTY ÓNIM mobile application. This consumer-facing technology empowers patients to verify medication authenticity instantly, access detailed product information, and participate actively in the country's pharmaceutical safety ecosystem, creating an additional layer of protection against falsified products.

Kazakhstan has adopted a methodical approach to implementation, with a pilot phase from 2019-2021 and a phased rollout targeting complete pharmaceutical serialization by 2025. This strategic timeline allows stakeholders to adapt operations gradually while ensuring the system achieves its goal of reducing the shadow pharmaceutical market by 50%, generating significant tax revenue, and strengthening legitimate business operations.